Metis Therapeutics Revenue, Growth & Competitor Profile

DBA METIS PHARMACEUTICALS US INC

Company Profile & Annual Report for Metis Therapeutics

Access the complete profile.

Metis Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	5417 Scientific Research & Development Services
Address	245 Main Street, 2nd Floor Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Metis Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Metis Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Metis Therapeutics is classified as operating in the Legal Services industry, NAICS Code 5411.

Metis Therapeutics Annual Revenue and Growth Rate

Metis Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Metis Therapeutics's revenues are gauged from an analysis of company filings.

Metis Therapeutics's Income Statement (based on Industry Averages)

Metis Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Metis Therapeutics is developing and marketing. Metis Therapeutics doesn't have any recent trademark applications, indicating Metis Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
METIS pharmaceutical preparations for target delivery of small molecules, RNA and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, solid dispersion solutions, gel, self-emulsifying subcutaneous injections, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience	06/25/2021
JI TAI pharmaceutical preparations for target delivery of small molecules, RNA and gene therapies for central nervous system diseases, liver diseases, lung diseases, cancer, immune system diseases, rare diseases caused by genetic anomalies, kidney diseases, gastrointestinal diseases, and infectious diseases; drug delivery agents in the form of lipid nanoparticles, solid dispersion solutions, gel, self-emulsifying subcutaneous injections, and sustained and controlled release formulations that facilitate the delivery of pharmaceutical preparations and improve the patients' medication experience	06/25/2021

See all trademarks and details in the Full Report.

Market Share of Metis Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Metis Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to Metis Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ROPES & GRAY	Boston, MA	100
MINTZ LEVIN COHN FERRIS GLOVSKY & POPEO P.C.	Boston, MA	38
CHOATE HALL & STEWART	Boston, MA	17
WOLF GREENFIELD & SACKS P.C.	Boston, MA	16
GOULSTON & STORRS PC	Boston, MA	15
MANNING GROSS & MASSENBURG	Boston, MA	14

Other Companies at 245 Main Street, 2nd Floor, Cambridge MA

Company	Headquarters	Revenue ($ MM)
ROOT CAPITAL	Cambridge, MA	100
IMMUNEERING	Cambridge, MA	54
CAMBRIDGE ADVISORS TO FAMILY ENTERPRISES	Cambridge, MA	9
ANKYRA THERAPEUTICS	Cambridge, MA	8
PROQR THERAPEUTICS I	Cambridge, MA	0

Future Competition: Metis Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Metis Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)